CALR and cancer: In our work, we showed the exposure of calreticulin in a subpopulation of ferroptotic cells shortly before their rupture, as well as ATP, HMGB1, CXCL1, TNF and IFN-β release in the course of a drug- and genetically induced models of ferroptosis in cancer cells.